Betamethasone valerate 0.1% ointment United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

betamethasone valerate 0.1% ointment

de pharmaceuticals - betamethasone valerate - cutaneous ointment - 1mg/1gram

Betamethasone valerate 0.1% cream United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

betamethasone valerate 0.1% cream

sigma pharmaceuticals plc - betamethasone valerate - cutaneous cream - 1mg/1gram

Betamethasone valerate 0.1% ointment United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

betamethasone valerate 0.1% ointment

sigma pharmaceuticals plc - betamethasone valerate - cutaneous ointment - 1mg/1gram

Betamethasone valerate 0.1% cream United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

betamethasone valerate 0.1% cream

actavis uk ltd - betamethasone valerate - cutaneous cream - 1mg/1gram

Betamethasone valerate 0.1% ointment United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

betamethasone valerate 0.1% ointment

actavis uk ltd - betamethasone valerate - cutaneous ointment - 1mg/1gram

CORTIVAL 1/2 betamethasone 0.5mg/g (as valerate) ointment tube Australia - English - Department of Health (Therapeutic Goods Administration)

cortival 1/2 betamethasone 0.5mg/g (as valerate) ointment tube

aspen pharmacare australia pty ltd - betamethasone valerate, quantity: 0.61 mg/g (equivalent: betamethasone, qty 0.5 mg/g) - ointment - excipient ingredients: liquid paraffin; white soft paraffin - indications as at 23 april 2004 : eczema including : atopic infantile, stasis and discoid eczemas. besnier's (flexural) prurigo. otitis externa. neurodermatoses including lichen simplex, lichen planus. seborrheic dermatitis, contact sensitivity reactions and allergies.

CORTIVAL 1/2 betamethasone 0.5mg/g (as valerate) cream tube Australia - English - Department of Health (Therapeutic Goods Administration)

cortival 1/2 betamethasone 0.5mg/g (as valerate) cream tube

aspen pharmacare australia pty ltd - betamethasone valerate, quantity: 0.61 mg/g (equivalent: betamethasone, qty 0.5 mg/g) - cream - excipient ingredients: cetomacrogol 1000; cetostearyl alcohol; white soft paraffin; liquid paraffin; purified water; chlorocresol; monobasic sodium phosphate; phosphoric acid; sodium hydroxide - indications as at 23 april 2004 : eczema including : atopic, infantile, stasis and discoid eczemas. besnier's (flexural) prurigo. otitis externa. neurodermatoses including lichen simplex, lichen planus. seborrheic dermatitis, contact sensitivity reactions and allergies.

CORTIVAL 1/5 betamethasone 0.2mg/g (as valerate) cream tube Australia - English - Department of Health (Therapeutic Goods Administration)

cortival 1/5 betamethasone 0.2mg/g (as valerate) cream tube

aspen pharmacare australia pty ltd - betamethasone valerate, quantity: 0.24 mg/g (equivalent: betamethasone, qty 0.2 mg/g) - cream - excipient ingredients: cetomacrogol 1000; cetostearyl alcohol; white soft paraffin; liquid paraffin; purified water; chlorocresol; monobasic sodium phosphate; phosphoric acid; sodium hydroxide - indications as at 23 april 2004 : eczema including: atopic, infantile, stasis and discoid eczemas. besnier's (flexural) prurigo. otitis externa. neurodermatoses including lichen simplex, lichen planus. seborrheic dermatitis, contact sensitivity reactions and allergies.

ANTROQUORIL betamethasone 0.2mg/g (as valerate) cream tube Australia - English - Department of Health (Therapeutic Goods Administration)

antroquoril betamethasone 0.2mg/g (as valerate) cream tube

organon pharma pty ltd - betamethasone valerate, quantity: 0.244 mg/g (equivalent: betamethasone, qty 0.2 mg/g) - cream - excipient ingredients: liquid paraffin; purified water; chlorocresol; cetostearyl alcohol; phosphoric acid; monobasic sodium phosphate dihydrate; cetomacrogol 1000; sodium hydroxide; white soft paraffin - antroquoril is indicated for maintenance therapy for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as atopic eczema, infantile eczema, nummular eczema, anogenital and senile pruritis, contact dermatitis, seborrhoeic dermatitis, neurodermatitis, solar dermatitis, statis dermatitis and psoriasis. indications as at 16 august 1999: antroquoril is indicated for maintenance therapy for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as atopic eczema, infantile eczema, nummular eczema, anogenital and senile pruritus, contact dermatitis, seborrhoeic dermatitis, neurodermatitis, solar dermatitis, stasis dermatitis and psoriasis

BETNOVATE 1/2 betamethasone 0.5mg/g (as valerate) ointment tube Australia - English - Department of Health (Therapeutic Goods Administration)

betnovate 1/2 betamethasone 0.5mg/g (as valerate) ointment tube

aspen pharmacare australia pty ltd - betamethasone valerate, quantity: 0.61 mg/g (equivalent: betamethasone, qty 0.5 mg/g) - ointment - excipient ingredients: liquid paraffin; white soft paraffin - indications as at 23 april 2004 : eczema including : atopic, infantile, stasis and discoid eczemas. besnier's (flexural) prurigo. otitis externa. neurodermatoses including lichen simplex, lichen planus. seborrheic dermatitis, contact sensitivity reactions and allergies.